CordenPharma Peptides, Lipids 
& Carbohydrates Platform

Your Expert Partner for Bio-Organic APIs

Platform Manager
Dr. Mimoun Ayoub
Director, Global Peptides, Lipids, Carbohydrates &
Injectables Platforms, 
CordenPharma International
  • Proven track record delivering world class manufacturing services from early stage to commercial supply including for most complex peptides (ex. Linaclotide, Enfuvirtide, Mifamurtide). Past experience from top leading pharmaceutical companies.
  • Proprietary process technologies for cost-effective manufacturing and a robust CMC dossier by reducing the number of chemical steps, increasing purity and decreasing raw material costs.
  • A unique combined expertise in peptides, carbohydrates and synthetic lipids offering access to a wide range of products to suit customer needs. Example for conjugates.
  • Multiple manufacturing locations across Europe and USA offering flexibility of supply.

Platform Description

The CordenPharma Peptides, Lipids & Carbohydrates Platform is comprised of Bio-organic APIs (Peptides, Lipids and Carbohydrates). CordenPharma experts manufacture Peptide APIs using solid-phase, solution-phase, and hybrid solid-solution phase technology at all scales. CordenPharma is additionally well-known for expertise in synthetic lipid and carbohydrate manufacturing.
 
With a streamlined process development, scale-up and large scale manufacture, CordenPharma’s Peptide expertise is supported by three peptide API plants: CordenPharma Colorado (USA), CordenPharma Brussels (BE), CordenPharma Switzerland (CH).

CordenPharma’s stream-lined process development and scale-up approach is enhanced by equipment design which mimics large scale production to avoid/limit deviations associated with the equipment engineering. We have designed state-of-the-art equipment to efficiently respond to customer needs at any scale and any stage of development.

CordenPharma is also recognized as an expert in:
  • Pegylated peptides
  • GLP-1 peptides and long peptide sequences
  • Cyclic peptides. Peptides with multiple (up to 4) disulfide bridges
  • Fatty acid and carbohydrate conjugated peptides
  • Arginine rich peptides
  • Peptide mimetic synthesis
  • Short peptide (up to 12 residues) very often with no preparative HPLC purification
More importantly, our success is based on a very close collaboration with our customers, flexibility and understanding of the industry dynamics.

Platform Capabilities

Peptides, Lipids & Carbohydrates
  • Synthetic Peptide API Production
    • Solid-phase,  Liquid-phase, Hybrid Synthesis 
      (Long Sequences, Cyclic Peptides & Conjugates)
    • cGMP & non-cGMP (multi-gram to multi-100 kg)
    • Pseudoproline Dipeptides Building Blocks
  • Synthetic Lipids
    • Drug Delivery (Glycero-phospholipids, Sphingolipids, Cationic Lipids)
    • API Products
  • Carbohydrates
    • Custom Manufacturing
    • Complex Carbohydrate Building Blocks (Shortened Delivery Time)
    • Carbohydrate Conjugates (For Vaccines, Receptor Targeting & Drug Delivery)

Facilities Included in Platform